Authors
Loading...
Analysis reveals ESG negatively affects firm value in public companies, highlighting stock returns as a significant moderator.
Mandasari et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: